Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $109.80 billion. The enterprise value is $128.58 billion.
| Market Cap | 109.80B |
| Enterprise Value | 128.58B |
Important Dates
The next confirmed earnings date is Wednesday, May 21, 2025, before market open.
| Earnings Date | May 21, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -2.53% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -2.53% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 86.19% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 26.18 and the forward PE ratio is 14.87. Medtronic's PEG ratio is 2.31.
| PE Ratio | 26.18 |
| Forward PE | 14.87 |
| PS Ratio | 3.26 |
| Forward PS | 3.15 |
| PB Ratio | 2.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.11 |
| P/OCF Ratio | 15.07 |
| PEG Ratio | 2.31 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.66, with an EV/FCF ratio of 23.52.
| EV / Earnings | 30.18 |
| EV / Sales | 3.87 |
| EV / EBITDA | 13.66 |
| EV / EBIT | 19.09 |
| EV / FCF | 23.52 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.90 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 2.75 |
| Debt / FCF | 4.87 |
| Interest Coverage | 8.90 |
Financial Efficiency
Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.49%.
| Return on Equity (ROE) | 8.44% |
| Return on Assets (ROA) | 4.66% |
| Return on Invested Capital (ROIC) | 5.49% |
| Return on Capital Employed (ROCE) | 8.62% |
| Revenue Per Employee | $349,463 |
| Profits Per Employee | $44,842 |
| Employee Count | 95,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.02 |
Taxes
In the past 12 months, Medtronic has paid $934.00 million in taxes.
| Income Tax | 934.00M |
| Effective Tax Rate | 17.88% |
Stock Price Statistics
The stock price has increased by +3.21% in the last 52 weeks. The beta is 0.83, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +3.21% |
| 50-Day Moving Average | 87.24 |
| 200-Day Moving Average | 86.99 |
| Relative Strength Index (RSI) | 53.43 |
| Average Volume (20 Days) | 6,031,894 |
Short Selling Information
The latest short interest is 12.24 million, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 12.24M |
| Short Previous Month | 10.84M |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.96% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Medtronic had revenue of $33.20 billion and earned $4.26 billion in profits. Earnings per share was $3.27.
| Revenue | 33.20B |
| Gross Profit | 21.78B |
| Operating Income | 6.74B |
| Pretax Income | 4.81B |
| Net Income | 4.26B |
| EBITDA | 9.41B |
| EBIT | 6.74B |
| Earnings Per Share (EPS) | $3.27 |
Balance Sheet
The company has $7.92 billion in cash and $26.61 billion in debt, giving a net cash position of -$18.65 billion or -$14.54 per share.
| Cash & Cash Equivalents | 7.92B |
| Total Debt | 26.61B |
| Net Cash | -18.65B |
| Net Cash Per Share | -$14.54 |
| Equity (Book Value) | 49.62B |
| Book Value Per Share | 38.49 |
| Working Capital | 10.67B |
Cash Flow
In the last 12 months, operating cash flow was $7.29 billion and capital expenditures -$1.83 billion, giving a free cash flow of $5.47 billion.
| Operating Cash Flow | 7.29B |
| Capital Expenditures | -1.83B |
| Free Cash Flow | 5.47B |
| FCF Per Share | $4.26 |
Margins
Gross margin is 65.59%, with operating and profit margins of 20.29% and 12.83%.
| Gross Margin | 65.59% |
| Operating Margin | 20.29% |
| Pretax Margin | 15.73% |
| Profit Margin | 12.83% |
| EBITDA Margin | 28.34% |
| EBIT Margin | 20.29% |
| FCF Margin | 16.47% |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 3.27%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.27% |
| Dividend Growth (YoY) | 1.45% |
| Years of Dividend Growth | 49 |
| Payout Ratio | 85.62% |
| Buyback Yield | 2.53% |
| Shareholder Yield | 5.79% |
| Earnings Yield | 3.88% |
| FCF Yield | 4.97% |
Analyst Forecast
The average price target for Medtronic is $94.71, which is 10.63% higher than the current price. The consensus rating is "Hold".
| Price Target | $94.71 |
| Price Target Difference | 10.63% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 4.94% |
| EPS Growth Forecast (5Y) | 19.30% |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Medtronic has an Altman Z-Score of 2.88 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.88 |
| Piotroski F-Score | 6 |